1. Home
  2. ALKS vs HSIC Comparison

ALKS vs HSIC Comparison

Compare ALKS & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkermes plc

ALKS

Alkermes plc

BUY

Current Price

$43.72

Market Cap

8.7B

Sector

Health Care

ML Signal

BUY

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$84.92

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKS
HSIC
Founded
1987
1932
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7B
9.8B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
ALKS
HSIC
Price
$43.72
$84.92
Analyst Decision
Buy
Buy
Analyst Count
14
16
Target Price
$43.43
$85.07
AVG Volume (30 Days)
1.3M
834.0K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.21
EPS
N/A
1.74
Revenue
$1,475,899,000.00
$13,201,995,000.00
Revenue This Year
$24.26
$6.12
Revenue Next Year
$4.47
$3.64
P/E Ratio
N/A
$48.87
Revenue Growth
N/A
5.94
52 Week Low
$26.99
$61.97
52 Week High
$55.67
$92.18

Technical Indicators

Market Signals
Indicator
ALKS
HSIC
Relative Strength Index (RSI) 32.05 36.83
Support Level $36.25 $82.77
Resistance Level $51.25 $88.78
Average True Range (ATR) 1.39 1.74
MACD -0.10 -0.59
Stochastic Oscillator 5.25 13.79

Price Performance

Historical Comparison
ALKS
HSIC

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

Share on Social Networks: